Pathology

Prof. Dr. Asuman Argon

Doctor and researcher İzmir Şehir Hastanesi İzmir
AdenocarcinomaPancreatic NeoplasmsStomach NeoplasmsGallbladder NeoplasmsCarcinoma, PapillaryAmyloidosisCarcinoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Adenocarcinoma 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Pancreatic Neoplasms 6 publications
  • Stomach Neoplasms 4 publications
  • Gallbladder Neoplasms 4 publications
  • Carcinoma, Papillary 3 publications
  • Amyloidosis 2 publications
  • Carcinoma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • Department name at the sourceTıbbi Patoloji Laboratuvarısaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workAdenocarcinomaExtracted from 8 publications · Model version —From source
  • Publications61 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-7406-0610ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046987/doktorlarimiz.html#asuman-argonsaglik.gov.tr

Scientific work

Publications on Adenocarcinoma

61 publications

  1. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103979 PMID 42194940 Open-access full textSource: OpenAlex

  2. The RATAB Framework: An Interpretable AI-Driven Radiographic Risk Stratification Model for Suspected Lung Lesions

    Journal of Imaging Informatics in Medicine, 2026

    DOI 10.1007/s10278-026-02303-5 PMID 42768277 Source: OpenAlex

  3. KIM-1 immunohistochemistry and early ccRCC recurrence outside adjuvant eligibility criteria: a two-centre exploratory study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-17191-9 Open-access full textSource: OpenAlex

  4. Molecular-Like Classification in Gastric Adenocarcinomas: Correlation with Clinicopathological Features and Prognosis

    International Journal of Surgical Pathology, 2026

    DOI 10.1177/10668969251397612 PMID 41493944 Source: OpenAlex

  5. Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study

    Cancers, 2026

    DOI 10.3390/cancers18203329 PMID 42938863 Open-access full textSource: ORCID

  6. Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy

    Diagnostics, 2026

    DOI 10.3390/diagnostics16091277 PMID 42121981 Open-access full textSource: ORCID

  7. Association of Abdominal Aortic Calcification with Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Retrospective Exploratory Study

    Asian Pacific journal of cancer prevention : APJCP, 2026

    DOI 10.31557/apjcp.2026.27.10.3723 PMID 42935064 Open-access full textSource: Europe PMC

  8. Pretreatment Hemoglobin, Albumin, Lymphocyte, and Platelet Score Predicts Pathological Response and Postoperative Pathological Findings in Locally Advanced Gastric Cancer

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-5-2 Open-access full textSource: OpenAlex

  9. Comparison of Baseline Systemic Inflammatory Indicators in Preoperative Treatment of Gastric Carcinoma

    Preprints.org, 2026

    DOI 10.20944/preprints202607.0514.v1 Open-access full textSource: OpenAlex

  10. Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176893 PMID 42739899 Open-access full textSource: OpenAlex

View all 61 publications